Bingong Li

549 total citations
25 papers, 420 citations indexed

About

Bingong Li is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Bingong Li has authored 25 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Bingong Li's work include Cardiac Fibrosis and Remodeling (6 papers), Mesenchymal stem cell research (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Bingong Li is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Mesenchymal stem cell research (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Bingong Li collaborates with scholars based in China, United States and South Korea. Bingong Li's co-authors include Xuelian Li, Zhiyang Li, Zeqi Zheng, Yong Li, Jingtian Peng, Menghong Wang, Zhe Li, Jin Zou, Jianbo Xiao and Ting Kang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Life Sciences.

In The Last Decade

Bingong Li

24 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingong Li China 11 198 168 82 67 50 25 420
Yoshiki Akakabe Japan 10 155 0.8× 144 0.9× 77 0.9× 44 0.7× 31 0.6× 18 429
Takanori Hayasaki Japan 12 200 1.0× 245 1.5× 128 1.6× 45 0.7× 81 1.6× 23 650
Keita Okayama Japan 9 164 0.8× 119 0.7× 108 1.3× 29 0.4× 35 0.7× 20 384
Ekaterina Legchenko Germany 10 307 1.6× 230 1.4× 110 1.3× 64 1.0× 124 2.5× 20 737
Qiwei Sun United States 12 224 1.1× 71 0.4× 75 0.9× 52 0.8× 27 0.5× 28 507
Mar Orriols Spain 14 285 1.4× 139 0.8× 95 1.2× 24 0.4× 82 1.6× 20 635
Xiuju Wu United States 11 181 0.9× 73 0.4× 130 1.6× 63 0.9× 53 1.1× 35 479
Naoto Ashizawa Japan 14 201 1.0× 319 1.9× 152 1.9× 44 0.7× 63 1.3× 29 598
Sofia Maysel-Auslender Israel 12 180 0.9× 124 0.7× 74 0.9× 22 0.3× 93 1.9× 18 400
Ming Cui China 13 188 0.9× 114 0.7× 90 1.1× 64 1.0× 32 0.6× 25 400

Countries citing papers authored by Bingong Li

Since Specialization
Citations

This map shows the geographic impact of Bingong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingong Li more than expected).

Fields of papers citing papers by Bingong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingong Li. The network helps show where Bingong Li may publish in the future.

Co-authorship network of co-authors of Bingong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bingong Li. A scholar is included among the top collaborators of Bingong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingong Li. Bingong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Kongmiao, et al.. (2024). Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation. European journal of medical research. 29(1). 244–244. 2 indexed citations
3.
Yang, Hao, et al.. (2023). Association between systemic inflammatory response index and left ventricular remodeling and systolic dysfunction in atrial fibrillation patients. BMC Cardiovascular Disorders. 23(1). 377–377. 6 indexed citations
4.
Li, Xuelian, et al.. (2022). Loss of α7nAChR enhances endothelial‐to‐mesenchymal transition after myocardial infarction via NF-κB activation. Experimental Cell Research. 419(1). 113300–113300. 5 indexed citations
5.
Zhou, Jia, Dingkun Wang, Bingong Li, et al.. (2021). Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension. Kidney & Blood Pressure Research. 46(4). 421–432. 13 indexed citations
6.
Hu, Jinxing, et al.. (2021). Metformin Attenuates Hypoxia-induced Endothelial Cell Injury by Activating the AMP-Activated Protein Kinase Pathway. Journal of Cardiovascular Pharmacology. 77(6). 862–874. 8 indexed citations
7.
Li, Zhiyang, Xue‐Lian Li, Yeqian Zhu, et al.. (2020). Protective effects of acetylcholine on hypoxia-induced endothelial-to-mesenchymal transition in human cardiac microvascular endothelial cells. Molecular and Cellular Biochemistry. 473(1-2). 101–110. 13 indexed citations
8.
Li, Xuelian, et al.. (2019). Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway. Life Sciences. 234. 116773–116773. 56 indexed citations
9.
Li, Xuelian, et al.. (2019). Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation. Biochemical and Biophysical Research Communications. 514(1). 1–8. 37 indexed citations
10.
Liu, Yanhua, Jin Zou, Bingong Li, et al.. (2017). RUNX3 modulates hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells. International Journal of Molecular Medicine. 40(1). 65–74. 27 indexed citations
11.
13.
Liu, Yanhua, et al.. (2016). [Knockdown of RUNX3 inhibits hypoxia-induced endothelial-to-mesenchymal transition of human cardiac microvascular endothelial cells].. PubMed. 32(12). 1627–1631. 1 indexed citations
14.
Zhang, Jian, et al.. (2015). Protective effects of Notch1 signaling activation against high glucose-induced myocardial cell injury: Analysis of its mechanisms of action. International Journal of Molecular Medicine. 36(3). 897–903. 14 indexed citations
15.
Li, Yong, et al.. (2014). Effect of NRG-1/ErbB Signaling Intervention on the Differentiation of Bone Marrow Stromal Cells Into Sinus Node–like Cells. Journal of Cardiovascular Pharmacology. 63(5). 434–440. 9 indexed citations
16.
Li, Bingong, et al.. (2013). Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats. Experimental and Therapeutic Medicine. 6(5). 1105–1112. 10 indexed citations
17.
Li, Bingong, Zeqi Zheng, Menghong Wang, et al.. (2012). Therapeutic effects of neuregulin-1 gene transduction in rats with myocardial infarction. Coronary Artery Disease. 23(7). 460–468. 30 indexed citations
18.
Li, Bingong, Qiutang Zeng, Hongxiang Wang, et al.. (2007). Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coronary Artery Disease. 18(3). 221–227. 39 indexed citations
19.
Li, Bingong. (2006). Comparison of mesenchymal stem cells from adipose tissue and bone marrow. 1 indexed citations
20.
Li, Bingong, Qiutang Zeng, Hongxiang Wang, & Xiaobo Mao. (2006). Effect of cytokines secreted by human adipose stromal cells on endothelial cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 26(4). 396–398. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026